PRONEO Trademark

Trademark Overview


On Monday, February 23, 2015, a trademark application was filed for PRONEO with the United States Patent and Trademark Office. The USPTO has given the PRONEO trademark a serial number of 86543079. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Thursday, September 22, 2016. This trademark is owned by Actavis, Inc. The PRONEO trademark is filed in the Pharmaceutical Products category with the following description:

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medic...
proneo

General Information


Serial Number86543079
Word MarkPRONEO
Filing DateMonday, February 23, 2015
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateThursday, September 22, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2016

Trademark Statements


Goods and ServicesOral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, Pharmaceutical preparations, namely, neuroprotective agents for treating and preserving brain function and structure; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Translation of Words in MarkThe wording "PRONEO" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, September 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALLERGAN SALES, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMADISON, NJ 07940

Party NameActavis, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameActavis, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Wednesday, January 3, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 22, 2016ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Thursday, September 22, 2016ABANDONMENT - AFTER INTER PARTES DECISION
Thursday, September 22, 2016OPPOSITION TERMINATED NO. 999999
Thursday, September 22, 2016OPPOSITION SUSTAINED NO. 999999
Wednesday, June 15, 2016OPPOSITION INSTITUTED NO. 999999
Wednesday, March 16, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 16, 2015ASSIGNED TO EXAMINER
Thursday, December 3, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 3, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 3, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 4, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 4, 2015NON-FINAL ACTION E-MAILED
Thursday, June 4, 2015NON-FINAL ACTION WRITTEN
Friday, May 29, 2015ASSIGNED TO EXAMINER
Monday, March 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 26, 2015NEW APPLICATION ENTERED IN TRAM